Quince Therapeutics, Inc. Cash Flow Quality Index
Quince Therapeutics, Inc. cash flow quality index. Quince Therapeutics, Inc. (QNCX) has a Cash Flow Quality Index of -0.21x as of March 2026. Operating cash flow of $-7.63 Million is below net income of $35.91 Million, suggesting accrual-heavy earnings not yet converted to cash. See QNCX financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Quince Therapeutics, Inc. Cash Flow Quality Index by Year (None–None)
Quince Therapeutics, Inc. cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Quince Therapeutics, Inc.. For the full cash flow conversion analysis, see Quince Therapeutics, Inc. (QNCX) cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|